Sort
15,842 grants matching “pancreatic cancer”
The biosynthesis of N-N bond-containing natural products
$372,422Emily Patricia Balskus · Harvard University · R01 · FY2020 · GM
The biosynthesis of N-N bond-containing natural products
$372,422Emily Patricia Balskus · Harvard University · R01 · FY2021 · GM
Targeting the autophagy-lysosome system to block pancreatic cancer
$372,359Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2025 · CA
Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer
$372,280Satyanarayana Rachagani · University Of Nebraska Medical Center · R01 · FY2021 · CA
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$372,237Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2019 · CA
Project 2: Targeting DNA replication in BRCA-associated breast cancer
$372,142Bing Xia · Rbhs -Cancer Institute Of New Jersey · P01 · FY2022 · CA
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation
$371,943Anna Moore · Massachusetts General Hospital · R01 · FY2010 · DK
Mechanistic Dissection of the Falconi Anemia Pathway of DNA Damage Response and Repair
$371,816Patrick Sung · University Of Texas Hlth Science Center · R01 · FY2019 · CA
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$371,711Kenneth P Olive · Columbia University Health Sciences · R01 · FY2019 · CA
NIA Confocal Imaging Facility
$371,560Fred Indig · National Institute On Aging · ZIC · FY2015 · AG
Integration of neo-antigen vaccines and immune checkpoint therapy
$371,552Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2024 · CA
Nanotechnology enabled targeting of p53 deficiency in human cancer
$371,490Xiaoming He · Ohio State University · R01 · FY2016 · CA
IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer
$371,406Michael Karin · University Of California, San Diego · R01 · FY2014 · CA
TARGETED ONCOGENESIS AND DIABETES
$371,357University Of California San Francisco · R37 · FY2000 · CA
SIGMA-2/PEPTIDOMIMETIC CONJUGATES TARGET APOPTOSIS IN PANCREATIC CANCER
$371,287William G Hawkins · Washington University · R01 · FY2016 · CA
SIGMA-2/PEPTIDOMIMETIC CONJUGATES TARGET APOPTOSIS IN PANCREATIC CANCER
$371,287William G Hawkins · Washington University · R01 · FY2015 · CA
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$371,255David G Denardo · Washington University · P50 · FY2018 · CA
Project 2: Targeting DNA replication in BRCA-associated breast cancer
$371,188Bing Xia · Rutgers Biomedical And Health Sciences · P01 · FY2023 · CA
Regulation of the Class IA PI 3-kinase PIK3CB
$371,156Jonathan M. Backer · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · GM
Mechanisms and therapeutic targets of cancer metastasis
$371,052Gregory L Beatty · University Of Pennsylvania · R01 · FY2021 · CA
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
$370,985Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
$370,985Cullen Mitsuo Taniguchi · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
The Evolution of PGD addiction in Human Pancreatic Cancer
$370,901Oliver Gene McDonald · Vanderbilt University Medical Center · R01 · FY2019 · CA
A systems-metabolism approach to identify mitochondria-dependent vulnerabilities in colorectal cancer
$370,878David Francis Kashatus · University Of Virginia · U54 · FY2024 · CA
Clinical trial development in cancer vaccines
$370,775Samir Khleif · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA